News

2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ 2012 Annual Meeting at the Impiana KLCC Hotel in Kuala Lumpur, Malaysia on Wednesday, November 14.

Also, we are sponsoring a lunch to allow the Sub-groups (Biology/Targets, Candidates, Critical Knowledge and Tools, and Clinical Trial Capacity) to meet and plan for activities for 2013. Please make plans to attend both events.

Event: WGND Sub-groups Working Lunch

WHEN: Wednesday, November 14, 2012, 12:00 to 13:00

WHERE: Impiana KLCC Hotel, 13, Jalan Pinang, 50450 Kuala Lumpur, Malaysia

DESCRIPTION: All WGND members and those interested in becoming members who will be attending the events in Kuala Lumpur are invited to a lunch sponsored by the WGND. The lunch will be an opportunity for members of each WGND Subgroup (Biology/Targets, Candidates, Critical Knowledge and Tools, Clinical Trial Capacity) to discuss and plan for 2013 activities and provide feedback on 2012 activities. If you have not officially joined a specific subgroup, we encourage you to attend the lunch and take the opportunity to see what the subgroups are doing and join in the discussions.


Event: 2012 WGND Annual Meeting

WHEN: Wednesday, November 14, 2012, 13:00 to 17:30

WHERE: Impiana KLCC Hotel, 13, Jalan Pinang, 50450 Kuala Lumpur, Malaysia

DESCRIPTION: The WGND will host our annual meeting at the start of the 43rd Union World Conference on Lung Health (The Union) in Kuala Lumpur, Malaysia. During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, review WGND 2012 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...